Patents by Inventor Tinte ITINTEANG

Tinte ITINTEANG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CANCER THERAPEUTIC
    Publication number: 20230364037
    Abstract: The present invention provides novel drug combinations, pharmaceutical compositions, as well as methods involving novel therapeutic regimes for targeting cancer stem cells, as well as methods of use thereof, for the treatment and management of cancerous and non-cancerous tumours in a patient. In particular, the present invention provides novel drug combinations and pharmaceutical compositions that target components of the Renin Angiotensin System shown to expressed by cancer stem cells.
    Type: Application
    Filed: May 22, 2023
    Publication date: November 16, 2023
    Inventors: Paul Frank Davis, Tinte Itinteang, Reginald Walter Marsh, Swee Thong Tan
  • CANCER THERAPEUTIC
    Publication number: 20200197335
    Abstract: The present invention provides novel drug combinations, pharmaceutical compositions, as well as methods involving novel therapeutic regimes for targeting cancer stem cells, as well as methods of use thereof, for the treatment and management of cancerous and non-cancerous tumours in a patient. In particular, the present invention provides novel drug combinations and pharmaceutical compositions that target components of the Renin Angiotensin System shown to expressed by cancer stem cells.
    Type: Application
    Filed: January 31, 2018
    Publication date: June 25, 2020
    Inventors: Paul Frank Davis, Tinte Itinteang, Reginald Walter Marsh, Swee Thong Tan
  • CANCER DIAGNOSIS AND THERAPY
    Publication number: 20200041521
    Abstract: The present invention provides a novel approach to cancer diagnosis and therapy of cancer by providing compositions and methods for the identification and specific targeting of the cancer stem cell populations present in a tumour to eradicate, or slow or prevent tumour (5) growth and spread, including the potential for tumour metastasis, by modulation of the Renin-Angiotensin System including, but not limited to, Renin Receptor, Angiotensin II Receptor (2) and a secreted form of the Renin Receptor.
    Type: Application
    Filed: March 4, 2019
    Publication date: February 6, 2020
    Inventors: Ranui Francesca Baillie, Paul Frank Davis, Tinte Itinteang, Swee Thong Tan
  • Cancer diagnosis and therapy
    Patent number: 10281472
    Abstract: The present invention provides a novel approach to cancer diagnosis and therapy of cancer by providing compositions and methods for the identification and specific targeting of the cancer stem cell populations present in a tumor to eradicate, or slow or prevent tumor (5) growth and spread, including the potential for tumor metastasis, by modulation of the Renin-Angiotensin System including, but not limited to, Renin Receptor, Angiotensin II Receptor (2) and a secreted form of the Renin Receptor.
    Type: Grant
    Filed: August 12, 2015
    Date of Patent: May 7, 2019
    Assignee: GILLIES MCINDOE RESEARCH INSTITUTE
    Inventors: Ranui Francesca Baillie, Paul Frank Davis, Tinte Itinteang, Swee Thong Tan
  • TREATMENT OF FIBROTIC CONDITIONS
    Publication number: 20190048416
    Abstract: The present invention provides a novel approach to the diagnosis, treatment and management of a fibrotic lesion by providing compositions and methods for the identification and specific targeting of the embryonic stem cell populations known to be associated with a fibrotic lesion, by modulation of the Renin-Angiotensin System.
    Type: Application
    Filed: November 30, 2016
    Publication date: February 14, 2019
    Inventors: Swee Thong Tan, Paul Frank Davis, Tinte Itinteang
  • TREATMENT OF VASCULAR ANOMALIES
    Publication number: 20170360829
    Abstract: The present invention provides a novel approach to the diagnosis, treatment and management of vascular anomalies by providing compositions and methods for the identification and specific targeting of the embryonic stem cell populations associated with vascular anomalies, by modulation of the Renin-Angiotensin System expressed by the stem cells.
    Type: Application
    Filed: February 27, 2017
    Publication date: December 21, 2017
    Inventors: Swee Thong Tan, Paul Frank Davis, Tinte Itinteang
  • CANCER DIAGNOSIS AND THERAPY
    Publication number: 20170234884
    Abstract: The present invention provides a novel approach to cancer diagnosis and therapy of cancer by providing compositions and methods for the identification and specific targeting of the cancer stem cell populations present in a tumour to eradicate, or slow or prevent tumour (5) growth and spread, including the potential for tumour metastasis, by modulation of the Renin-Angiotensin System including, but not limited to, Renin Receptor, Angiotensin II Receptor (2) and a secreted form of the Renin Receptor.
    Type: Application
    Filed: August 12, 2015
    Publication date: August 17, 2017
    Inventors: Ranui Francesca BAILLIE, Paul Frank DAVIS, Tinte ITINTEANG, Swee Thong TAN